25 XP   0   0   10

Diagnos Inc
Buy, Hold or Sell?

Let's analyse Diagnos together

PenkeI guess you are interested in Diagnos Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Diagnos Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Diagnos Inc

I send you an email if I find something interesting about Diagnos Inc.

Quick analysis of Diagnos (30 sec.)










What can you expect buying and holding a share of Diagnos? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.04
Expected worth in 1 year
C$-0.06
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
C$-0.02
Return On Investment
-5.9%

For what price can you sell your share?

Current Price per Share
C$0.30
Expected price per share
C$0.23 - C$0.35
How sure are you?
50%

1. Valuation of Diagnos (5 min.)




Live pricePrice per Share (EOD)

C$0.30

Intrinsic Value Per Share

C$-0.44 - C$-0.42

Total Value Per Share

C$-0.47 - C$-0.46

2. Growth of Diagnos (5 min.)




Is Diagnos growing?

Current yearPrevious yearGrowGrow %
How rich?-$2m-$661k-$1.1m-63.1%

How much money is Diagnos making?

Current yearPrevious yearGrowGrow %
Making money-$552.2k-$449.8k-$102.3k-18.5%
Net Profit Margin-1,662.4%-433.8%--

How much money comes from the company's main activities?

3. Financial Health of Diagnos (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#114 / 120

Most Revenue
#115 / 120

Most Profit
#43 / 120

Most Efficient
#116 / 120

What can you expect buying and holding a share of Diagnos? (5 min.)

Welcome investor! Diagnos's management wants to use your money to grow the business. In return you get a share of Diagnos.

What can you expect buying and holding a share of Diagnos?

First you should know what it really means to hold a share of Diagnos. And how you can make/lose money.

Speculation

The Price per Share of Diagnos is C$0.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Diagnos.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Diagnos, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.04. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Diagnos.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.01-2.6%-0.01-2.4%-0.01-2.0%-0.01-2.1%-0.01-2.2%
Usd Book Value Change Per Share0.00-0.4%0.00-1.1%0.00-1.4%0.000.2%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.4%0.00-1.1%0.00-1.4%0.000.2%0.00-0.3%
Usd Price Per Share0.30-0.31-0.16-0.23-0.14-
Price to Earnings Ratio-9.70--10.52--7.16--9.64--4.98-
Price-to-Total Gains Ratio-242.75--120.43--45.35--100.04--57.51-
Price to Book Ratio-10.91--13.14--53.23--313.03--157.84-
Price-to-Total Gains Ratio-242.75--120.43--45.35--100.04--57.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.21792
Number of shares4588
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (4588 shares)-14.813.19
Gains per Year (4588 shares)-59.2312.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-59-690133
20-118-12802516
30-178-18703829
40-237-24605142
50-296-30506455
60-355-36407668
70-415-42308981
80-474-482010294
90-533-5410115107
100-592-6000127120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%6.081.00.06.9%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%9.031.00.022.5%26.061.00.029.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.087.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%9.031.00.022.5%26.061.00.029.9%

Fundamentals of Diagnos

About Diagnos Inc

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Fundamental data was last updated by Penke on 2024-04-19 01:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Diagnos Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Diagnos earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Diagnos to the Health Information Services industry mean.
  • A Net Profit Margin of -1,553.9% means that $-15.54 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Diagnos Inc:

  • The MRQ is -1,553.9%. The company is making a huge loss. -2
  • The TTM is -1,662.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,553.9%TTM-1,662.4%+108.5%
TTM-1,662.4%YOY-433.8%-1,228.6%
TTM-1,662.4%5Y-935.1%-727.3%
5Y-935.1%10Y-768.5%-166.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,553.9%-20.7%-1,533.2%
TTM-1,662.4%-20.0%-1,642.4%
YOY-433.8%-30.6%-403.2%
5Y-935.1%-35.6%-899.5%
10Y-768.5%-43.2%-725.3%
1.1.2. Return on Assets

Shows how efficient Diagnos is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Diagnos to the Health Information Services industry mean.
  • -96.7% Return on Assets means that Diagnos generated $-0.97 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Diagnos Inc:

  • The MRQ is -96.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -80.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-96.7%TTM-80.8%-15.8%
TTM-80.8%YOY-57.6%-23.2%
TTM-80.8%5Y-61.7%-19.1%
5Y-61.7%10Y-63.9%+2.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.7%-6.7%-90.0%
TTM-80.8%-6.5%-74.3%
YOY-57.6%-6.5%-51.1%
5Y-61.7%-6.2%-55.5%
10Y-63.9%-8.6%-55.3%
1.1.3. Return on Equity

Shows how efficient Diagnos is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Diagnos to the Health Information Services industry mean.
  • 0.0% Return on Equity means Diagnos generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Diagnos Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-106.5%+106.5%
5Y-106.5%10Y-62.8%-43.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.6%+6.6%
TTM--7.2%+7.2%
YOY--7.7%+7.7%
5Y-106.5%-9.6%-96.9%
10Y-62.8%-9.7%-53.1%

1.2. Operating Efficiency of Diagnos Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Diagnos is operating .

  • Measures how much profit Diagnos makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Diagnos to the Health Information Services industry mean.
  • An Operating Margin of -1,300.2% means the company generated $-13.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Diagnos Inc:

  • The MRQ is -1,300.2%. The company is operating very inefficient. -2
  • The TTM is -694.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,300.2%TTM-694.9%-605.3%
TTM-694.9%YOY-397.7%-297.2%
TTM-694.9%5Y-677.5%-17.4%
5Y-677.5%10Y-599.4%-78.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,300.2%-19.8%-1,280.4%
TTM-694.9%-18.2%-676.7%
YOY-397.7%-23.2%-374.5%
5Y-677.5%-20.2%-657.3%
10Y-599.4%-31.6%-567.8%
1.2.2. Operating Ratio

Measures how efficient Diagnos is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 14.00 means that the operating costs are $14.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Diagnos Inc:

  • The MRQ is 14.002. The company is inefficient in keeping operating costs low. -1
  • The TTM is 19.007. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.002TTM19.007-5.005
TTM19.007YOY5.150+13.857
TTM19.0075Y10.336+8.671
5Y10.33610Y7.966+2.370
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ14.0021.343+12.659
TTM19.0071.383+17.624
YOY5.1501.383+3.767
5Y10.3361.394+8.942
10Y7.9661.324+6.642

1.3. Liquidity of Diagnos Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Diagnos is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.70 means the company has $0.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Diagnos Inc:

  • The MRQ is 0.698. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.915. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.698TTM0.915-0.217
TTM0.915YOY1.288-0.372
TTM0.9155Y1.696-0.781
5Y1.69610Y1.659+0.037
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6981.770-1.072
TTM0.9151.811-0.896
YOY1.2882.055-0.767
5Y1.6962.582-0.886
10Y1.6592.668-1.009
1.3.2. Quick Ratio

Measures if Diagnos is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Diagnos to the Health Information Services industry mean.
  • A Quick Ratio of 0.89 means the company can pay off $0.89 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Diagnos Inc:

  • The MRQ is 0.891. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.583. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.891TTM0.583+0.307
TTM0.583YOY1.476-0.893
TTM0.5835Y2.235-1.652
5Y2.23510Y2.076+0.159
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8911.059-0.168
TTM0.5831.185-0.602
YOY1.4761.813-0.337
5Y2.2351.978+0.257
10Y2.0761.999+0.077

1.4. Solvency of Diagnos Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Diagnos assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Diagnos to Health Information Services industry mean.
  • A Debt to Asset Ratio of 4.44 means that Diagnos assets are financed with 443.8% credit (debt) and the remaining percentage (100% - 443.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Diagnos Inc:

  • The MRQ is 4.438. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.622. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.438TTM3.622+0.816
TTM3.622YOY1.907+1.716
TTM3.6225Y1.727+1.895
5Y1.72710Y2.227-0.500
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4380.381+4.057
TTM3.6220.385+3.237
YOY1.9070.407+1.500
5Y1.7270.411+1.316
10Y2.2270.448+1.779
1.4.2. Debt to Equity Ratio

Measures if Diagnos is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Diagnos to the Health Information Services industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Diagnos Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.468-1.468
5Y1.46810Y0.916+0.551
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.600-0.600
TTM-0.578-0.578
YOY-0.608-0.608
5Y1.4680.718+0.750
10Y0.9160.610+0.306

2. Market Valuation of Diagnos Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Diagnos generates.

  • Above 15 is considered overpriced but always compare Diagnos to the Health Information Services industry mean.
  • A PE ratio of -9.70 means the investor is paying $-9.70 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Diagnos Inc:

  • The EOD is -7.097. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.699. Based on the earnings, the company is expensive. -2
  • The TTM is -10.525. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.097MRQ-9.699+2.602
MRQ-9.699TTM-10.525+0.826
TTM-10.525YOY-7.161-3.364
TTM-10.5255Y-9.641-0.883
5Y-9.64110Y-4.981-4.660
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-7.097-1.617-5.480
MRQ-9.699-2.160-7.539
TTM-10.525-1.939-8.586
YOY-7.161-3.622-3.539
5Y-9.641-4.656-4.985
10Y-4.981-4.959-0.022
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Diagnos Inc:

  • The EOD is -7.835. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.708. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.081. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.835MRQ-10.708+2.873
MRQ-10.708TTM-17.081+6.373
TTM-17.081YOY-8.798-8.282
TTM-17.0815Y-14.956-2.125
5Y-14.95610Y-7.509-7.447
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-7.835-1.725-6.110
MRQ-10.708-2.152-8.556
TTM-17.081-3.191-13.890
YOY-8.798-5.417-3.381
5Y-14.956-3.884-11.072
10Y-7.509-3.133-4.376
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Diagnos is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of -10.91 means the investor is paying $-10.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Diagnos Inc:

  • The EOD is -7.980. Based on the equity, the company is expensive. -2
  • The MRQ is -10.905. Based on the equity, the company is expensive. -2
  • The TTM is -13.141. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.980MRQ-10.905+2.926
MRQ-10.905TTM-13.141+2.236
TTM-13.141YOY-53.234+40.093
TTM-13.1415Y-313.026+299.885
5Y-313.02610Y-157.836-155.190
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-7.9801.811-9.791
MRQ-10.9051.855-12.760
TTM-13.1411.880-15.021
YOY-53.2343.032-56.266
5Y-313.0263.953-316.979
10Y-157.8364.093-161.929
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Diagnos Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.004+163%-0.006+235%0.001-277%-0.001-30%
Book Value Per Share---0.038-0.032-14%-0.012-68%-0.007-82%-0.018-52%
Current Ratio--0.6980.915-24%1.288-46%1.696-59%1.659-58%
Debt To Asset Ratio--4.4383.622+23%1.907+133%1.727+157%2.227+99%
Debt To Equity Ratio----0%-0%1.468-100%0.916-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.011-0.010-5%-0.008-24%-0.009-16%-0.009-13%
Free Cash Flow Per Share---0.010-0.007-28%-0.007-31%-0.007-31%-0.007-23%
Free Cash Flow To Equity Per Share---0.002-0.001-34%0.001-436%-0.001-64%0.000-77%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.420--------
Intrinsic Value_10Y_min---0.435--------
Intrinsic Value_1Y_max---0.029--------
Intrinsic Value_1Y_min---0.032--------
Intrinsic Value_3Y_max---0.097--------
Intrinsic Value_3Y_min---0.107--------
Intrinsic Value_5Y_max---0.178--------
Intrinsic Value_5Y_min---0.193--------
Market Cap22994580.000-37%31425926.00032192412.000-2%17245935.000+82%24642524.900+28%15233909.250+106%
Net Profit Margin---15.539-16.624+7%-4.338-72%-9.351-40%-7.685-51%
Operating Margin---13.002-6.949-47%-3.977-69%-6.775-48%-5.994-54%
Operating Ratio--14.00219.007-26%5.150+172%10.336+35%7.966+76%
Pb Ratio-7.980+27%-10.905-13.141+21%-53.234+388%-313.026+2770%-157.836+1347%
Pe Ratio-7.097+27%-9.699-10.525+9%-7.161-26%-9.641-1%-4.981-49%
Price Per Share0.300-37%0.4100.420-2%0.225+82%0.322+28%0.199+106%
Price To Free Cash Flow Ratio-7.835+27%-10.708-17.081+60%-8.798-18%-14.956+40%-7.509-30%
Price To Total Gains Ratio-177.621+27%-242.748-120.434-50%-45.351-81%-100.041-59%-57.506-76%
Quick Ratio--0.8910.583+53%1.476-40%2.235-60%2.076-57%
Return On Assets---0.967-0.808-16%-0.576-40%-0.617-36%-0.639-34%
Return On Equity----0%-0%-1.0650%-0.6280%
Total Gains Per Share---0.002-0.004+163%-0.006+235%0.001-277%-0.001-30%
Usd Book Value---2093238.550-1790378.964-14%-661015.646-68%-381561.794-82%-1012978.329-52%
Usd Book Value Change Per Share---0.001-0.003+163%-0.004+235%0.001-277%-0.001-30%
Usd Book Value Per Share---0.027-0.023-14%-0.009-68%-0.005-82%-0.013-52%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.008-0.007-5%-0.006-24%-0.006-16%-0.007-13%
Usd Free Cash Flow---532975.661-382145.238-28%-366036.774-31%-366305.723-31%-408082.095-23%
Usd Free Cash Flow Per Share---0.007-0.005-28%-0.005-31%-0.005-31%-0.005-23%
Usd Free Cash Flow To Equity Per Share---0.001-0.001-34%0.000-436%0.000-64%0.000-77%
Usd Market Cap16703262.912-37%22827792.64623384568.077-2%12527447.184+82%17900330.087+28%11065911.679+106%
Usd Price Per Share0.218-37%0.2980.305-2%0.163+82%0.234+28%0.144+106%
Usd Profit---588414.509-552204.014-6%-449867.510-24%-493315.201-16%-573071.016-3%
Usd Revenue--37867.23235674.412+6%103433.367-63%63286.837-40%139349.489-73%
Usd Total Gains Per Share---0.001-0.003+163%-0.004+235%0.001-277%-0.001-30%
 EOD+2 -6MRQTTM+9 -22YOY+9 -225Y+5 -2710Y+6 -26

3.2. Fundamental Score

Let's check the fundamental score of Diagnos Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.097
Price to Book Ratio (EOD)Between0-1-7.980
Net Profit Margin (MRQ)Greater than0-15.539
Operating Margin (MRQ)Greater than0-13.002
Quick Ratio (MRQ)Greater than10.891
Current Ratio (MRQ)Greater than10.698
Debt to Asset Ratio (MRQ)Less than14.438
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.967
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Diagnos Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.281
Ma 20Greater thanMa 500.290
Ma 50Greater thanMa 1000.287
Ma 100Greater thanMa 2000.339
OpenGreater thanClose0.310
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets838
Total Liabilities3,720
Total Stockholder Equity-2,882
 As reported
Total Liabilities 3,720
Total Stockholder Equity+ -2,882
Total Assets = 838

Assets

Total Assets838
Total Current Assets551
Long-term Assets287
Total Current Assets
Cash And Cash Equivalents 105
Short-term Investments 200
Net Receivables 198
Other Current Assets 48
Total Current Assets  (as reported)551
Total Current Assets  (calculated)551
+/-0
Long-term Assets
Property Plant Equipment 287
Long-term Assets Other 0
Long-term Assets  (as reported)287
Long-term Assets  (calculated)287
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities790
Long-term Liabilities2,930
Total Stockholder Equity-2,882
Total Current Liabilities
Short-term Debt 268
Short Long Term Debt 185
Accounts payable 339
Other Current Liabilities 162
Total Current Liabilities  (as reported)790
Total Current Liabilities  (calculated)954
+/- 165
Long-term Liabilities
Long term Debt 2,723
Capital Lease Obligations 290
Long-term Liabilities  (as reported)2,930
Long-term Liabilities  (calculated)3,013
+/- 83
Total Stockholder Equity
Common Stock37,000
Retained Earnings -49,838
Accumulated Other Comprehensive Income 9,957
Total Stockholder Equity (as reported)-2,882
Total Stockholder Equity (calculated)-2,882
+/-0
Other
Capital Stock37,000
Cash and Short Term Investments 305
Common Stock Shares Outstanding 72,968
Current Deferred Revenue20
Liabilities and Stockholders Equity 838
Net Debt 3,093
Net Invested Capital 26
Net Working Capital -238
Short Long Term Debt Total 3,198



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-30
> Total Assets 
341
470
420
251
137
148
238
712
1,859
1,070
692
377
277
916
1,000
964
926
925
1,566
1,602
1,440
1,402
1,751
4,872
4,783
4,569
3,949
2,663
2,215
1,694
2,614
2,274
1,969
1,636
1,735
1,514
3,787
3,308
2,959
2,652
1,902
1,412
834
2,222
1,833
1,857
1,377
1,578
1,046
2,333
1,618
1,172
918
1,969
1,372
1,271
1,149
1,961
1,950
1,309
2,710
1,804
3,033
1,524
858
839
1,854
1,207
567
792
662
2,434
1,950
1,949
2,028
1,950
1,880
1,566
1,086
1,542
907
806
1,296
823
1,264
955
838
8389551,2648231,2968069071,5421,0861,5661,8801,9502,0281,9491,9502,4346627925671,2071,8548398581,5243,0331,8042,7101,3091,9501,9611,1491,2711,3721,9699181,1721,6182,3331,0461,5781,3771,8571,8332,2228341,4121,9022,6522,9593,3083,7871,5141,7351,6361,9692,2742,6141,6942,2152,6633,9494,5694,7834,8721,7511,4021,4401,6021,5669259269641,0009162773776921,0701,859712238148137251420470341
   > Total Current Assets 
104
261
243
116
31
69
166
651
1,798
1,011
636
315
215
858
920
886
852
855
1,485
1,506
1,350
1,265
1,583
4,665
4,526
4,244
3,634
2,266
1,855
1,315
2,210
1,820
1,461
1,114
1,088
1,202
3,543
3,116
2,768
2,283
1,560
1,080
523
2,085
1,622
1,676
1,226
1,447
887
2,216
1,525
1,082
835
1,799
1,158
978
721
1,559
1,686
1,093
1,776
830
1,914
790
629
683
1,703
1,093
490
712
593
2,338
1,862
1,549
1,644
1,591
1,544
1,253
813
1,289
680
602
1,106
575
1,043
636
551
5516361,0435751,1066026801,2898131,2531,5441,5911,6441,5491,8622,3385937124901,0931,7036836297901,9148301,7761,0931,6861,5597219781,1581,7998351,0821,5252,2168871,4471,2261,6761,6222,0855231,0801,5602,2832,7683,1163,5431,2021,0881,1141,4611,8202,2101,3151,8552,2663,6344,2444,5264,6651,5831,2651,3501,5061,4858558528869208582153156361,0111,7986511666931116243261104
       Cash And Cash Equivalents 
33
194
197
48
2
40
119
537
906
908
484
258
165
707
736
53
27
137
300
340
64
92
347
315
361
302
130
130
72
182
130
256
148
142
211
347
266
163
376
276
148
349
0
1,351
547
467
656
875
253
415
701
352
230
254
498
477
162
885
880
190
437
271
1,355
150
204
45
418
138
46
252
307
570
225
325
958
359
236
419
503
421
251
194
663
297
394
139
105
10513939429766319425142150341923635995832522557030725246138418452041501,3552714371908808851624774982542303527014152538756564675471,351034914827637616326634721114214825613018272130130302361315347926434030013727537367071652584849089065371194024819719433
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
419
221
12
612
618
635
335
365
3,382
2,836
2,454
0
1,683
1,337
740
1,690
1,287
1,038
593
660
455
2,759
2,259
1,678
1,702
904
398
101
60
100
100
51
51
51
1,051
151
157
102
1,103
104
104
104
84
84
85
785
85
85
86
86
86
801
556
51
231
31
1,302
1,252
1,002
502
1,001
1,001
503
500
500
300
0
0
0
300
300
200
2003003000003005005005031,0011,0015021,0021,2521,302312315155680186868685857858584841041041041,1031021571511,051515151100100601013989041,7021,6782,2592,7594556605931,0381,2871,6907401,3371,68302,4542,8363,38236533563561861212221419000000000000000
       Net Receivables 
55
67
20
46
14
21
47
108
808
101
152
50
43
147
182
407
592
693
564
532
637
827
863
933
1,296
1,458
1,235
420
416
379
388
252
262
372
215
381
395
516
597
237
472
298
394
565
845
938
444
429
529
661
623
508
453
391
520
339
410
564
698
783
539
423
416
506
262
416
416
298
333
173
213
321
253
162
133
176
195
222
234
326
316
330
368
243
243
14
198
198142432433683303163262342221951761331622533212131733332984164162625064164235397836985644103395203914535086236615294294449388455653942984722375975163953812153722622523883794164201,2351,4581,296933863827637532564693592407182147435015210180810847211446206755
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,264
0
0
0
0
0
0
0
0
0
49
10
28
21
0
0
0
0
0
0
0
0
0
0
0
14
0
0
0
0
11
0
10
96
80
120
120
102
102
101
71
71
71
51
51
51
20
21
21
27
21
33
15
84
92
56
30
20
21
0
48
4802120305692841533212721212051515171717110110210212012080961001100001400000000000212810490000000002,26400000000000000000000000000
   > Long-term Assets 
237
209
177
135
106
79
72
61
61
59
56
62
62
58
80
78
74
70
81
95
90
137
168
207
257
325
315
397
360
379
405
454
509
523
647
311
245
192
190
369
342
332
311
137
211
182
151
131
158
118
93
90
84
170
214
292
428
403
264
217
934
974
1,119
734
229
155
152
114
76
80
69
96
88
399
384
359
336
313
273
253
227
204
190
248
222
319
287
28731922224819020422725327331333635938439988966980761141521552297341,11997493421726440342829221417084909311815813115118221113731133234236919019224531164752350945440537936039731532525720716813790958170747880586262565961617279106135177209237
       Property Plant Equipment 
137
129
117
87
79
73
67
57
52
51
49
46
47
44
65
57
56
50
48
63
59
57
71
112
152
145
131
103
88
68
64
62
93
82
80
85
72
58
51
76
72
59
53
65
55
41
36
33
31
25
28
27
39
117
169
141
152
253
213
207
162
353
320
257
194
135
146
104
76
80
69
65
57
368
353
328
304
283
273
253
227
204
190
248
222
319
287
2873192222481902042272532732833043283533685765698076104146135194257320353162207213253152141169117392728253133364155655359727651587285808293626468881031311451521127157596348505657654447464951525767737987117129137
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
766
618
797
477
35
20
6
10
0
0
0
31
31
31
31
32
32
30
0
0
0
0
0
0
0
0
0
0000000003032323131313100010620354777976187660130000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
4
0
0
7
16
0
0
15
21
18
20
33
32
31
41
57
95
105
169
171
169
141
105
62
44
46
44
40
26
28
20
13
21
0
0
0
25
0
0
18
17
16
14
12
14
9
17
21
22
41
35
34
9
6
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000012369343541222117914121416171800250002113202826404446446210514116917116910595574131323320182115001670040000000
       Long-term Assets Other 
100
80
60
48
27
6
5
0
9
8
0
0
15
14
0
0
0
0
0
0
0
40
40
0
0
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114
76
80
69
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000698076114000000000000000000000000000000000000000001000404000000001415008905627486080100
> Total Liabilities 
856
766
506
515
486
686
734
841
704
245
262
215
161
158
174
171
189
166
106
180
219
101
249
666
780
478
587
253
293
280
328
292
286
357
366
332
252
302
295
308
295
320
335
476
548
730
610
1,231
1,342
1,220
1,175
1,397
1,787
3,225
3,347
4,420
4,706
5,421
4,660
6,884
4,233
4,148
5,412
5,161
5,430
6,140
6,202
6,290
570
754
1,032
615
602
947
861
818
870
849
869
1,655
1,704
2,016
2,815
2,771
3,541
3,707
3,720
3,7203,7073,5412,7712,8152,0161,7041,6558698498708188619476026151,0327545706,2906,2026,1405,4305,1615,4124,1484,2336,8844,6605,4214,7064,4203,3473,2251,7871,3971,1751,2201,3421,231610730548476335320295308295302252332366357286292328280293253587478780666249101219180106166189171174158161215262245704841734686486515506766856
   > Total Current Liabilities 
856
766
506
515
486
402
412
841
258
245
262
215
161
158
174
171
189
166
106
180
219
101
249
666
780
478
587
253
293
280
328
292
286
357
366
332
252
302
295
308
295
320
335
476
548
730
610
605
452
304
238
1,176
1,787
1,488
1,533
1,983
2,213
2,905
2,631
4,053
785
555
935
663
836
2,438
2,393
2,481
414
585
1,013
581
531
650
583
550
622
613
532
659
708
738
779
719
757
809
790
7908097577197797387086595326136225505836505315811,0135854142,4812,3932,4388366639355557854,0532,6312,9052,2131,9831,5331,4881,7871,176238304452605610730548476335320295308295302252332366357286292328280293253587478780666249101219180106166189171174158161215262245258841412402486515506766856
       Short-term Debt 
0
0
0
0
0
0
0
372
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
715
1,225
992
1,048
1,541
1,555
1,795
1,672
3,111
193
9
16
16
19
1,609
1,675
1,710
68
293
750
304
301
366
215
204
204
196
193
190
190
190
310
0
0
0
268
268000310190190190193196204204215366301304750293681,7101,6751,60919161691933,1111,6721,7951,5551,5411,0489921,22571500000000000000000000000000000000000000000003720000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,247
3,281
3,642
3,603
4,493
4,514
4,613
1,591
1,636
1,670
28
238
695
268
272
275
125
125
125
125
125
125
125
125
245
169
184
185
185
185185184169245125125125125125125125125275272268695238281,6701,6361,5914,6134,5144,4933,6033,6423,2811,2470000000000000000000000000000000000000000000000000000000000
       Accounts payable 
856
766
506
515
486
402
412
332
258
245
199
142
76
69
174
171
189
47
106
180
219
101
89
345
281
245
0
0
0
0
0
0
0
0
0
86
207
201
248
97
0
0
0
253
0
0
0
328
0
0
0
130
0
0
0
161
360
745
396
621
344
407
545
472
327
601
213
143
231
122
132
68
99
113
225
190
279
232
193
278
391
391
299
288
305
332
339
3393323052882993913912781932322791902251139968132122231143213601327472545407344621396745360161000130000328000253000972482012078600000000024528134589101219180106471891711746976142199245258332412402486515506766856
       Other Current Liabilities 
0
0
0
0
0
0
0
136
0
0
63
73
84
90
0
0
0
119
0
0
0
0
160
0
0
0
295
170
195
187
184
204
207
278
213
163
0
0
0
164
254
278
294
181
507
723
604
187
410
249
0
287
388
378
322
181
333
319
703
626
248
138
710
285
369
295
875
1,247
227
287
248
410
131
318
267
305
139
343
274
184
126
140
159
7
9
0
162
1620971591401261842743431393052673181314102482872271,2478752953692857101382486267033193331813223783882870249410187604723507181294278254164000163213278207204184187195170295000160000011900090847363001360000000
   > Long-term Liabilities 
0
0
0
0
0
284
322
0
446
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-267
0
0
0
0
0
0
0
626
890
916
938
221
0
1,737
1,814
2,436
2,494
2,516
2,029
2,831
3,448
3,593
4,477
4,498
4,594
3,702
3,810
3,809
157
169
19
34
71
297
278
268
248
235
337
996
996
1,277
2,036
2,052
2,784
2,898
2,930
2,9302,8982,7842,0522,0361,2779969963372352482682782977134191691573,8093,8103,7024,5944,4984,4773,5933,4482,8312,0292,5162,4942,4361,8141,73702219389168906260000000-267000000000000000000000000000000446032228400000
> Total Stockholder Equity
-516
-296
-86
-265
-349
-538
-495
-129
1,155
825
431
162
116
758
826
794
737
759
1,460
1,422
1,221
1,301
1,502
4,206
4,004
4,090
3,362
2,410
1,922
1,414
2,287
1,982
1,683
1,280
1,369
1,182
3,536
3,006
2,663
2,343
1,607
1,092
499
1,746
1,285
1,128
767
347
-297
1,113
442
-225
-868
-1,256
-1,975
-3,149
-3,557
-3,460
-2,710
-5,575
-1,524
-2,344
-2,379
-3,637
-4,572
-5,302
-4,348
-5,083
-4
38
-370
1,819
1,349
1,002
1,167
1,132
1,010
717
216
-114
-797
-1,210
-1,519
-1,948
-2,277
-2,752
-2,882
-2,882-2,752-2,277-1,948-1,519-1,210-797-1142167171,0101,1321,1671,0021,3491,819-37038-4-5,083-4,348-5,302-4,572-3,637-2,379-2,344-1,524-5,575-2,710-3,460-3,557-3,149-1,975-1,256-868-2254421,113-2973477671,1281,2851,7464991,0921,6072,3432,6633,0063,5361,1821,3691,2801,6831,9822,2871,4141,9222,4103,3624,0904,0044,2061,5021,3011,2211,4221,4607597377948267581161624318251,155-129-495-538-349-265-86-296-516
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,238
15,238
15,238
15,238
16,052
16,052
16,052
16,052
16,052
16,052
18,162
18,162
18,162
18,163
18,163
18,163
18,163
18,163
19,133
19,839
20,368
21,662
21,881
21,881
21,881
21,879
22,012
23,284
23,698
29,745
30,278
30,278
33,667
33,667
33,667
34,354
34,757
35,368
35,576
35,576
35,680
35,680
35,680
35,680
35,915
36,204
0
37,000
37,000036,20435,91535,68035,68035,68035,68035,57635,57635,36834,75734,35433,66733,66733,66730,27830,27829,74523,69823,28422,01221,87921,88121,88121,88121,66220,36819,83919,13318,16318,16318,16318,16318,16318,16218,16218,16216,05216,05216,05216,05216,05216,05215,23815,23815,23815,238000000000000000000000000000000000000000
   Retained Earnings -49,838-49,028-48,279-47,526-46,744-46,230-45,710-44,992-44,267-43,662-43,104-42,384-41,754-41,181-40,829-40,333-39,069-38,502-37,955-36,950-36,203-35,169-34,068-33,111-32,069-31,525-30,690-32,705-28,852-28,914-27,973-27,284-26,496-25,780-24,792-24,092-23,408-22,737-21,700-21,015-20,470-20,021-19,818-19,374-19,184-18,565-17,988-17,330-16,892-16,419-15,860-14,457-14,532-14,325-13,843-13,383-12,986-12,542-11,993-11,472-10,565-9,766-9,789-9,392-9,068-9,197-9,234-8,994-8,910-8,652-8,469-8,377-8,314-8,016-7,876-7,795-7,454-7,038-6,476-6,046-5,981-5,950-6,029-5,897-5,702-5,494-5,397
   Accumulated Other Comprehensive Income 
535
535
535
535
535
251
213
163
89
42
64
87
116
146
0
0
0
0
0
0
0
0
0
0
0
-14
-23
-20
-13
4
73
142
163
190
436
176
0
0
0
4,436
4,358
4,419
4,446
-46
5,051
5,097
5,185
5,309
5,351
5,689
5,689
5,705
5,760
6,360
6,358
5,972
6,252
6,321
6,303
6,762
7,504
7,300
7,809
7,593
7,617
7,855
8,571
8,169
8,207
8,261
8,421
8,485
8,511
8,516
8,567
8,760
8,746
8,804
8,908
9,199
9,232
9,341
24
0
0
0
9,957
9,957000249,3419,2329,1998,9088,8048,7468,7608,5678,5168,5118,4858,4218,2618,2078,1698,5717,8557,6177,5937,8097,3007,5046,7626,3036,3216,2525,9726,3586,3605,7605,7055,6895,6895,3515,3095,1855,0975,051-464,4464,4194,3584,436000176436190163142734-13-20-23-140000000000014611687644289163213251535535535535535
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
4,347
4,663
5,081
5,097
5,145
5,161
5,272
5,755
7,542
7,821
7,821
7,870
7,876
8,628
9,140
9,170
9,206
9,411
10,371
10,415
10,455
10,498
10,570
13,598
13,793
13,871
13,950
13,902
13,928
13,952
15,199
15,223
15,363
15,415
15,465
15,463
19,396
19,425
19,555
0
0
0
0
5,114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,700
6,932
7,504
7,300
7,809
7,593
7,617
7,855
8,571
8,169
8,207
8,261
8,421
8,485
8,511
8,516
8,567
8,760
8,746
8,804
8,908
9,199
9,232
9,341
9,521
9,664
9,798
0
0
009,7989,6649,5219,3419,2329,1998,9088,8048,7468,7608,5678,5168,5118,4858,4218,2618,2078,1698,5717,8557,6177,5937,8097,3007,5046,9324,700000000000000005,114000019,55519,42519,39615,46315,46515,41515,36315,22315,19913,95213,92813,90213,95013,87113,79313,59810,57010,49810,45510,41510,3719,4119,2069,1709,1408,6287,8767,8707,8217,8217,5425,7555,2725,1615,1455,0975,0814,6634,347



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue486
Cost of Revenue-793
Gross Profit-307-307
 
Operating Income (+$)
Gross Profit-307
Operating Expense-2,707
Operating Income-2,222-3,014
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,930
Selling And Marketing Expenses0
Operating Expense2,7071,930
 
Net Interest Income (+$)
Interest Income8
Interest Expense-279
Other Finance Cost-0
Net Interest Income-271
 
Pretax Income (+$)
Operating Income-2,222
Net Interest Income-271
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,481-2,234
EBIT - interestExpense = -279
-2,481
-2,202
Interest Expense279
Earnings Before Interest and Taxes (EBIT)0-2,202
Earnings Before Interest and Taxes (EBITDA)-2,101
 
After tax Income (+$)
Income Before Tax-2,481
Tax Provision-0
Net Income From Continuing Ops-2,481-2,481
Net Income-2,481
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net12271
 

Technical Analysis of Diagnos
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Diagnos. The general trend of Diagnos is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Diagnos's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Diagnos Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.35 < 0.35 < 0.35.

The bearish price targets are: 0.29 > 0.28 > 0.23.

Tweet this
Diagnos Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Diagnos Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Diagnos Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Diagnos Inc. The current macd is 0.00581042.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Diagnos price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Diagnos. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Diagnos price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Diagnos Inc Daily Moving Average Convergence/Divergence (MACD) ChartDiagnos Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Diagnos Inc. The current adx is 21.92.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Diagnos shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Diagnos Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Diagnos Inc. The current sar is 0.29.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Diagnos Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Diagnos Inc. The current rsi is 52.28. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Diagnos Inc Daily Relative Strength Index (RSI) ChartDiagnos Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Diagnos Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -3/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Diagnos price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Diagnos Inc Daily Stochastic Oscillator ChartDiagnos Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Diagnos Inc. The current cci is 32.87.

Diagnos Inc Daily Commodity Channel Index (CCI) ChartDiagnos Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Diagnos Inc. The current cmo is 3.85381547.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Diagnos Inc Daily Chande Momentum Oscillator (CMO) ChartDiagnos Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Diagnos Inc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Diagnos is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Diagnos Inc Daily Williams %R ChartDiagnos Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Diagnos Inc.

Diagnos Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Diagnos Inc. The current atr is 0.02225052.

Diagnos Inc Daily Average True Range (ATR) ChartDiagnos Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Diagnos Inc. The current obv is 673,721.

Diagnos Inc Daily On-Balance Volume (OBV) ChartDiagnos Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Diagnos Inc. The current mfi is 69.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Diagnos Inc Daily Money Flow Index (MFI) ChartDiagnos Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Diagnos Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Diagnos Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Diagnos Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.281
Ma 20Greater thanMa 500.290
Ma 50Greater thanMa 1000.287
Ma 100Greater thanMa 2000.339
OpenGreater thanClose0.310
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Diagnos with someone you think should read this too:
  • Are you bullish or bearish on Diagnos? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Diagnos? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Diagnos Inc

I send you an email if I find something interesting about Diagnos Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Diagnos Inc.

Receive notifications about Diagnos Inc in your mailbox!